RxDoctor Payments Data

Michael Oboyle, MD

Orthopaedic Surgery · Greenville, SCNPI 1750479598

Payments from drug & device makers

$1,295in general payments, 2019–2025

Across 16 payments — averaging $80.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$841
  • Carbofix Orthopedics Inc$219
  • Medical Device Business Services, Inc.$116
  • Smith+Nephew$64
  • Carbofix Spine Inc$36
  • Pacira Therapeutics, Inc.$18

What the payments were for

  • Consulting fees$25520%
  • Travel & lodging$1169%
  • Food & beverage$92371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)10$841
Carbofix Orthopedics Inc1$219
Medical Device Business Services, Inc.1$116
Smith+Nephew2$64
Carbofix Spine Inc1$36
Pacira Therapeutics, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,295 in reported general payments places this provider in the 35th percentile of 325 orthopaedic surgery providers in South Carolina.

See all orthopaedic surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$299,982
Medicare patients
434
Services billed
1,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$111

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →